DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$4.13 USD
+0.09 (2.23%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.13 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | 18.75% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.60 |
Next Year | -0.70 |
EPS (TTM) | -0.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.16 | -0.60 | -0.70 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.16 | -0.16 | -0.60 | -0.70 |
Low Estimate | -0.16 | -0.16 | -0.60 | -0.70 |
Year ago EPS | -0.12 | -0.14 | -0.60 | -0.60 |
Year over Year Growth Est. | -33.33% | -14.29% | 0.00% | -16.67% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.16 | -0.60 | -0.70 |
7 Days Ago | -0.16 | -0.16 | -0.60 | -0.70 |
30 Days Ago | -0.16 | -0.16 | -0.60 | -0.70 |
60 Days Ago | -0.16 | -0.16 | -0.63 | -0.70 |
90 Days Ago | -0.18 | -0.18 | -0.67 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.16 | -0.60 | -0.70 |
Zacks Consensus Estimate | -0.16 | -0.16 | -0.60 | -0.70 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.14 | -0.14 | -0.12 | NA |
Estimate | -0.16 | -0.16 | -0.14 | -0.14 | NA |
Difference | 0.03 | 0.02 | 0.00 | 0.02 | 0.02 |
Surprise | 18.75% | 12.50% | 0.00% | 14.29% | 11.39% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more